Literature DB >> 7853180

Kinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules.

W H Dantzler1, K K Evans, S H Wright.   

Abstract

Kinetics of the first 15 s of para-aminohippurate (PAH) uptake across the basolateral membrane of single isolated S2 segments of rabbit proximal renal tubules and the effects of probenecid and cysteine conjugates on them were determined. For PAH uptake in control tubules, Kt (the concentration of PAH at 1/2 Jmax) was about 110 microM and Jmax (maximal rate of PAH transport) was about 6.5 pmol min-1 nl-1. In tubules preloaded with alpha-ketoglutarate (alpha-KG), thereby stimulating PAH/alpha-KG countertransport, Jmax doubled with little change in Kt. Probenecid cis-inhibited PAH uptake with an apparent Ki of about 13 to 15 microM whether or not the tubules were preloaded with alpha-KG. High probenecid concentrations cis-inhibited PAH uptake by > 98%, indicating that essentially all movement of PAH across the basolateral membrane is carrier mediated. Zwitterionic nephrotoxic cysteine conjugate, S-(1,2-dichlorovinyl)-L-cysteine (DCVC), and nontoxic cysteine conjugate, S-(2-benzothiazole)-L-cysteine (BTC) cis-inhibited PAH uptake (apparent Ki: approximately 86 microM for DCVC; approximately 37 microM for BTC) at least as effectively as their negatively charged N-acetyl derivatives (NAC-DCVC and NAC-BTC) (apparent Ki: approximately 310 microM for NAC-DCVC; approximately 35 microM for NAC-BTC). The inhibition by both DCVC and NAC-DCVC was competitive in nature. NAC-DCVC also cis-inhibited net transepithelial secretion of PAH by isolated, perfused S2 segments. The presence of DCVC and NAC-DCVC, as well as PAH itself, in the bathing medium trans-stimulated the 15 s efflux of PAH across the basolateral membrane of single S2 segments with oil-filled lumens. These data indicate that these cysteine conjugates and their N-acetyl derivatives, not only interact competitively with the PAH transporter, but are transported by it.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853180

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Relationships between the renal handling of DMPS and DMSA and the renal handling of mercury.

Authors:  Rudolfs K Zalups; Christy C Bridges
Journal:  Chem Res Toxicol       Date:  2012-06-15       Impact factor: 3.739

2.  Implications of the alternating access model for organic anion transporter kinetics.

Authors:  Satish A Eraly
Journal:  J Membr Biol       Date:  2008-11-18       Impact factor: 1.843

3.  Competitive inhibition of p-aminohippurate transport by quinapril in rabbit renal basolateral membrane vesicles.

Authors:  W Akarawut; D E Smith
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

4.  Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.

Authors:  Olivia Perwitasari; Xiuzhen Yan; Scott Johnson; Caleb White; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

5.  Transport of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine, a metabolite of trichloroethylene, by mouse multidrug resistance associated protein 2 (Mrp2).

Authors:  Kirill Tsirulnikov; Natalia Abuladze; Myong-Chul Koag; Debra Newman; Karoline Scholz; Galyna Bondar; Quansheng Zhu; Nuraly K Avliyakulov; Wolfgang Dekant; Kym Faull; Ira Kurtz; Alexander Pushkin
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-06       Impact factor: 4.219

Review 6.  Organic anion transporter 3 inhibitors as potential novel antihypertensives.

Authors:  Satish A Eraly
Journal:  Pharmacol Res       Date:  2008-10-04       Impact factor: 7.658

Review 7.  Metabolism of trichloroethylene.

Authors:  L H Lash; J W Fisher; J C Lipscomb; J C Parker
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

8.  siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.

Authors:  Olivia Perwitasari; Abhijeet Bakre; S Mark Tompkins; Ralph A Tripp
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.